Table 5.
Variable | TSH | FT4 | FT3 | |||
---|---|---|---|---|---|---|
rs | p | rs | p | rs | p | |
FA right frontal lobe AVG | 0.07 | 0.7 | 0.05 | 0.80 | 0.07 | 0.68 |
FA right frontal lobe DEV | −0.39 * | 0.02 | 0.13 | 0.47 | 0.27 | 0.12 |
FA left frontal lobe AVG | 0.09 | 0.61 | −0.08 | 0.65 | 0.06 | 0.74 |
FA left frontal lobe DEV | −0.17 | 0.34 | 0.06 | 0.74 | 0.22 | 0.22 |
FA_ACC right AVG | 0.02 | 0.91 | 0.10 | 0.59 | 0.14 | 0.43 |
FA_ACC right DEV | 0.30 | 0.08 | 0.20 | 0.26 | 0.24 | 0.18 |
FA_ACC left AVG | 0.24 | 0.19 | −0.08 | 0.67 | −0.36 * | 0.04 |
FA_ACC left DEV | 0.08 | 0.64 | −0.12 | 0.51 | −0.20 | 0.26 |
ACC_LIPCR | 0.03 | 0.9 | −0.02 | 0.90 | 0.23 | 0.25 |
ACC_LACCR | −0.05 | 0.79 | 0.01 | 0.97 | 0.08 | 0.69 |
ACC_ALACR | 0.09 | 0.66 | −0.02 | 0.91 | −0.03 | 0.89 |
ACC_NAACR | 0.10 | 0.6 | 0.14 | 0.50 | −0.11 | 0.58 |
ACC_GLUCR | −0.12 | 0.54 | 0.13 | 0.51 | 0.44 * | 0.02 |
ACC_GABACR | −0.16 | 0.44 | −0.08 | 0.68 | 0.19 | 0.35 |
ACC_GLNCR | 0.28 | 0.16 | −0.07 | 0.74 | −0.13 | 0.52 |
ACC_CHOCR | 0.22 | 0.26 | 0.10 | 0.61 | 0.25 | 0.20 |
ACC_GLCCR | 0.32 | 0.1 | −0.06 | 0.76 | −0.37 | 0.06 |
ACC_MICR | −0.10 | 0.62 | 0.48 * | 0.01 | 0.48 * | 0.01 |
ACC_GLUGLNGSHCR | −0.21 | 0.29 | 0.24 | 0.23 | −0.23 | 0.25 |
ACC_GLCCR_A | 0.12 | 0.54 | −0.14 | 0.49 | 0.27 | 0.17 |
ACC_MICR_A | −0.30 | 0.12 | −0.18 | 0.37 | −0.07 | 0.73 |
*—p ≤ 0.05; ACC—anterior cingulate cortex; ALA—alanine; AVG—average; CHO—choline; CR—creatine; DEV—standard deviation; FA—fractional anisotropy; FT3—free triiodothyronine; FT4—free thyroxin; GABA –γ-aminobutyric acid; GLC—glucose; GLN—glutamine; GLU—glutamate; GLUGLNGSH—GLU + GLN + GSH complex; LAC—lactates; LIP—lipids; MI—myoinositol; NAA—N-acetyl-aspartate; p—p-value; rs—Spearman correlation; TSH—thyrotropin.